B
BBROS
Hospital reservation / required app clicks
About BBROS
BBROS is a South Korean healthcare technology company established on December 23, 2013. The company operates 'DdocDoc', a mobile healthcare service platform designed to streamline the hospital and clinic experience for patients. Initially founded by Song Yong-beom and a team of five other co-founders, including a former Naver CTO and an ex-foreign enterprise consultant, the company has since transitioned its leadership. As of May 2022, BBROS is led by co-CEOs Gosung Yoon and Hyeong-seok Kim. Gosung Yoon brought extensive experience from the healthcare sector, having previously served as the CFO at BBROS, while Hyeong-seok Kim has a background in major IT platform companies such as Naver, Meta (formerly Facebook), and Kakao.
The core of BBROS's business is the DdocDoc application, which provides an all-in-one service for patients. The platform's key function is its ability to directly integrate with the Electronic Medical Records (EMR) systems of hospitals and clinics. This integration enables users to search for nearby medical facilities, book appointments in real-time, check their queue status remotely, and reduce in-person wait times. The service is particularly popular among parents of young children, helping to avoid long waits at pediatric clinics. Beyond appointment management, DdocDoc's features include mobile payment of medical bills, simplified submission of health check-up questionnaires, and a streamlined process for filing claims with indemnity insurance providers.
BBROS generates revenue through a subscription-based model. While basic features remain accessible, core services like unlimited appointment booking require a monthly or annual membership fee. This model was introduced to secure a sustainable revenue stream after years of operating at a loss despite significant user growth. The company primarily serves the general public in South Korea, aiming to change the conventional habits of accessing medical care. Since 2020, BBROS has been an affiliate of the GC Group, following the acquisition of its largest shareholder, EMR market leader UBcare.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jan 2022 | $0 | — | Undisclosed | — |
| SERIES D✓Equity / VC | Jul 2020 | $33M | $130M | LG Uplus · DS Asset Management | — |
Growth signals
Latest recorded traffic for BBROS is 3.6K monthly website visits, down 20% over the last three months. BBROS's team declined 5.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
OculusmaximaOculus Maxima: AI-driven telemedicine for eye exams |
Nottingham, United Kingdom | Operational | — | $92K | — |
IMU BiosciencesAI-powered platform decoding the immune system |
London, United Kingdom | Operational | |||
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning |
Oxford, United Kingdom | Operational | |||
Microplate DxRapid diagnostic platform for antibiotic susceptibility testing |
Glasgow, United Kingdom | Operational | |||
UnforgedDigital mental wellness for Gen Z-centric organisations |
London, United Kingdom | Operational | |||
ElevateMeAt-home blood tests with personalized AI-driven health insights |
London, United Kingdom | Operational | |||
Cohesion MedicalMaking citizens more empowered, health more integrated and sciences more innovative |
Glasgow, United Kingdom | Operational | |||
Isolere BioProvides treatment for orthopedic patients |
Durham, United States | Acquired |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Hanwha Investment & Securities
Series B and later4 investors entered at this stage
Shinhan Invest
Dong-A ST
LG Uplus
DS Asset Management
Other known investors1 additional known investor
Samsung Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BBROS on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BBROS’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







